CRELD2 Polyclonal antibody
CRELD2 Polyclonal Antibody for WB, IHC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
WB, IHC, ELISA
Conjugate
Unconjugated
Cat no : 27017-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | human placenta tissue, SH-SY5Y cells, U2OS cells |
Positive IHC detected in | human placenta tissue, human pancreas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
WB | See 1 publications below |
Product Information
The immunogen of 27017-1-AP is CRELD2 Fusion Protein expressed in E. coli.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | CRELD2 fusion protein Ag25553 |
Full Name | cysteine-rich with EGF-like domains 2 |
Calculated Molecular Weight | 44 kDa |
Observed Molecular Weight | 30-45 kDa |
GenBank Accession Number | BC050675 |
Gene Symbol | CRELD2 |
Gene ID (NCBI) | 79174 |
RRID | AB_2880723 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
Product Specific Protocols | |
---|---|
WB protocol for CRELD2 antibody 27017-1-AP | Download protocol |
IHC protocol for CRELD2 antibody 27017-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Mol Ther Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma |